title: Lipid-like Nanoparticles for Small Interfering RNA Delivery to Endothelial Cells.
abstract: Here we develop nanoparticles composed of lipid-like materials (lipidoids) to facilitate non-viral delivery of small interfering RNA (siRNA) to endothelial cells (ECs). Nanoparticles composed of siRNA and lipidoids with small size (~200 nm) and positive charge (~34 mV) were formed by self assembly of lipidoids and siRNA. Ten lipidoids were synthesized and screened for their ability to facilitate the delivery of siRNA into ECs. Particles composed of leading lipidoids show significantly better delivery to ECs than a leading commercially-available transfection reagent, Lipofectamine 2000. As a model of potential therapeutic application, nanoparticles composed of the top performing lipidoid, NA114, were studied for their ability to deliver siRNA targeting anti-angiogenic factor (SHP-1) to human ECs. Silencing of SHP-1 expression significantly enhanced EC proliferation and decreased EC apoptosis under a simulated ischemic condition.
authors: Department of Anesthesiology, Children's Hospital Boston, Harvard Medical School, 300, Longwood Avenue, Boston, MA 02115 (USA).
authors: Seung-Woo
authors: SW
authors: Cho
authors: Michael
authors: M
authors: Goldberg
authors: Sun Mi
authors: SM
authors: Son
authors: Qiaobing
authors: Q
authors: Xu
authors: Fan
authors: F
authors: Yang
authors: Ying
authors: Y
authors: Mei
authors: Said
authors: S
authors: Bogatyrev
authors: Robert
authors: R
authors: Langer
authors: Daniel G
authors: DG
authors: Anderson
references: Mol Ther. 2009 May;17(5):872-9
references: 19259063
references: FASEB J. 2005 Dec;19(14):2054-6
references: 16223786
references: Brain Res. 2003 Jun 6;974(1-2):88-98
references: 12742627
references: Cardiovasc Res. 2001 Mar;49(4):863-71
references: 11230986
references: Proc Natl Acad Sci U S A. 2008 Aug 19;105(33):11915-20
references: 18695239
references: Bioconjug Chem. 2006 Sep-Oct;17(5):1162-9
references: 16984124
references: Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3426-30
references: 19208807
references: Mol Ther. 2006 Oct;14(4):476-84
references: 16829204
references: Nat Biotechnol. 2006 Aug;24(8):1005-15
references: 16823371
references: Atherosclerosis. 2007 Mar;191(1):33-9
references: 16725144
references: PLoS Med. 2006 Apr;3(4):e96
references: 16464133
references: Arterioscler Thromb Vasc Biol. 2002 Feb 1;22(2):238-42
references: 11834522
references: Nat Biotechnol. 2008 May;26(5):561-9
references: 18438401
references: Gene Ther. 2005 Mar;12(5):461-6
references: 15616603
references: Nat Med. 2002 Jan;8(1):61-7
references: 11786908
references: Nature. 2004 Nov 11;432(7014):173-8
references: 15538359
references: Nat Rev Drug Discov. 2009 Feb;8(2):129-38
references: 19180106
references: Stem Cells. 2006 Feb;24(2):416-25
references: 16253984
references: J Biol Chem. 2006 Feb 10;281(6):3711-21
references: 16326706
references: Nat Biotechnol. 2005 Aug;23(8):1002-7
references: 16041363
references: Nature. 2006 May 4;441(7089):111-4
references: 16565705
references: J Biol Chem. 1999 Nov 12;274(46):33057-63
references: 10551875
references: Methods Mol Biol. 2005;309:261-72
references: 15990406
references: Nat Rev Drug Discov. 2007 Jun;6(6):443-53
references: 17541417
references: Nature. 2004 Jul 8;430(6996):161-4
references: 15241403
references: Curr Gene Ther. 2004 Dec;4(4):357-72
references: 15578987
references: Nat Biotechnol. 2007 Oct;25(10):1149-57
references: 17873866
references: Nat Biotechnol. 2005 Jun;23(6):709-17
references: 15908939
references: Nat Genet. 2008 Feb;40(2):170-80
references: 18176562
references: J Biol Chem. 2000 Apr 14;275(15):11216-21
references: 10753929
references: Biochem Biophys Res Commun. 2008 Nov 7;376(1):158-63
references: 18765230